LIFEVANTAGE CORP Form 10-K: Annual report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-08-27: Form 10-K; Period of report 2026-06-30; Description 10-K; Document lfvn-20260630.htm.
- 2025-09-04: Form 10-K; Period of report 2025-06-30; Description 10-K; Document lfvn-20250630.htm.
- 2024-08-28: Form 10-K; Period of report 2024-06-30; Description 10-K; Document lfvn-20240630.htm.
- 2023-08-28: Form 10-K; Period of report 2023-06-30; Description 10-K; Document lfvn-20230630.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-08-27 | 10-K | 2026-06-30 | 10-K | lfvn-20260630.htm |
| 2025-09-04 | 10-K | 2025-06-30 | 10-K | lfvn-20250630.htm |
| 2024-08-28 | 10-K | 2024-06-30 | 10-K | lfvn-20240630.htm |
| 2023-08-28 | 10-K | 2023-06-30 | 10-K | lfvn-20230630.htm |
| 2022-08-23 | 10-K | 2022-06-30 | 10-K | lfvn-20220630.htm |
| 2021-08-19 | 10-K | 2021-06-30 | 10-K | lfvn-20210630.htm |
| 2020-08-18 | 10-K | 2020-06-30 | 10-K | lfvn-20200630.htm |
| 2019-08-14 | 10-K | 2019-06-30 | 10-K | lfvn0630201910k.htm |
| 2018-08-15 | 10-K | 2018-06-30 | 10-K | lfvn_06302018x10k.htm |
| 2017-09-07 | 10-K | 2017-06-30 | 10-K | lfvn_06302017x10k.htm |
| 2016-12-12 | 10-K | 2016-06-30 | 10-K | lfvn_06302016x10k.htm |
| 2015-09-01 | 10-K | 2015-06-30 | 10-K | lfvn_06302015x10k.htm |
| 2014-09-10 | 10-K | 2014-06-30 | 10-K | lfvn_06302014x10k.htm |
| 2013-09-12 | 10-K | 2013-06-30 | 10-K | lfvn_06302013x10k.htm |
| 2012-09-10 | 10-K | 2012-06-30 | FORM 10-K | d406524d10k.htm |
| 2011-09-28 | 10-K | 2011-06-30 | FORM 10-K | d225491d10k.htm |
| 2010-09-15 | 10-K | 2010-06-30 | FORM 10-K | a57251e10vk.htm |
| 2009-09-28 | 10-K | 2009-06-30 | FORM 10-K | d69291e10vk.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |